Developmental Research Program

发展研究计划

• 批准号: 10251119
• 负责人: ANIL K SOOD
• 金额: $ 7.44万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-22 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10251119
• 关键词: Address; Area; Award; Basic Science; Budgets; Cancer Center; Clinical; Clinical Investigator; Clinical Research; Collaborations; Communities; Data; Development; Discipline; Doctor of Medicine; Early Diagnosis; Early treatment; Financial Support; Funding; Future; Goals; Grant; Human; Institution; Leadership; Malignant neoplasm of ovary; Medical center; Mentorship; Ovarian; Peer Review; Plant Roots; Population Research; Prevention; Program Research Project Grants; Publications; Publishing; Research; Research Personnel; Research Project Grants; Resources; Rest; Scientist; Specimen; Techniques; Texas; Translational Research; Work; anticancer research; design; innovation; novel; ovarian cancer prevention; patient population; programs; recruit; sound; supportive environment; translational study

Developmental Research Program SUMMARY/ABSTRACT The purpose of the Developmental Research Program (DRP) is to fund promising projects by investigators whose current work may not focus exclusively on ovarian cancer, but who propose highly innovative translational studies of ovarian cancer that could become full SPORE projects or compete successfully for funding outside of the SPORE. The DRP provides a unique venue for making available significant financial support, and for demonstrating active institutional support, through a program that is rapidly responsive to new ideas or initiatives. Moreover, this program is rooted in a spirit of collaboration espoused by the SPORE investigators, who have an extensive track-record of bringing investigators from other disciplines into ovarian cancer research. The strength of the DRP rests in its ability to make available financial support needed to access all the critical expertise and resources within the entire SPORE. This will allow us to develop collaborative, multi-investigator, multi-institutional research projects with the support of innovative, investigator-initiated projects that have the potential to flourish into reliable and productive translational research projects that make a path from basic and/or population research projects into research focused on human clinical specimens/patient populations. Over the course of the previously-funded Ovarian SPORE grants since 2000, we have supported 48 DRPs. Overall, 14 former recipients of DRPs have received peer-reviewed funding in ovarian cancer as PI, Co- PI or Co-Investigator with eight as PIs (three DOD, two R01, one R21, one R03 and two CPRIT). Two recipients have been awarded OCRF funds (one Multi-Investigator Award and one Liz Tilberis Scholar). More recently, four recipients have been awarded six peer-reviewed ovarian cancer grants as PI (three R01, one R21, two CPRIT) and one Liz Tilberis Scholar award from the OCRF. Overall, recipients have published 281 peer-reviewed publications regarding ovarian cancer (38 specific to their DRP project) since receiving a DRP award. Additionally, six former awardees have participated in full SPORE projects after completing a DRP project.

开发研究计划概要/摘要 发展研究计划（DRP）的目的是资助有前途的项目， 研究人员目前的工作可能不完全集中在卵巢癌，但谁提出高度 卵巢癌的创新转化研究，可能成为完整的SPORE项目或竞争 成功获得了SPORE以外的资金。DRP提供了一个独特的场所， 重要的财政支持，并通过一个方案， 对新的想法或倡议迅速作出反应。此外，这一计划植根于一种精神， SPORE调查人员支持的合作，他们有着广泛的记录， 其他学科的研究人员进入卵巢癌研究。DRP的优势在于其 有能力提供获得内部所有关键专业知识和资源所需的财政支持 整个孢子。这将使我们能够开发协作，多研究者，多机构 研究项目与创新的支持，科研人员发起的项目，有可能 蓬勃发展成可靠和富有成效的转化研究项目，使从基础和/或 人口研究项目的研究重点是人类临床标本/患者人群。超过 自2000年以来，在先前资助的卵巢孢子赠款的过程中，我们已经支持了48个DRPs。 总体而言，14名前DRP接受者作为PI，Co， PI或合作研究者，其中8名为PI（3名DOD、2名R 01、1名R21、1名R 03和2名CPRIT）。两 获奖者获得了OCRF基金（一个多研究者奖和一个Liz Tilestan奖学金）。 最近，四个收件人已被授予六个同行评审的卵巢癌赠款作为PI（三个 R 01、一个R21、两个CPRIT）和一个OCRF的Liz Tilberis学者奖。总的来说，接受者有 发表了281篇关于卵巢癌的同行评审出版物（38篇针对其DRP项目） 获得了DRP奖。此外，六名前获奖者参加了完整的SPORE项目 完成一个DRP项目后。